S&P 500   3,283.22 (-1.27%)
DOW   28,855.84 (-1.04%)
QQQ   221.85 (-1.22%)
AAPL   318.58 (-0.20%)
FB   216.42 (-1.52%)
GOOGL   1,465.76 (-1.28%)
AMZN   1,851.75 (-1.74%)
CGC   22.71 (-7.53%)
NVDA   249.33 (-1.40%)
BABA   211.74 (-3.37%)
MU   57.36 (-3.11%)
TSLA   557.57 (-2.56%)
AMD   49.61 (-4.06%)
T   38.25 (-0.98%)
F   8.97 (-1.86%)
NFLX   349.09 (-0.15%)
PRI   122.73 (-2.25%)
BAC   33.36 (-2.23%)
DIS   139.47 (-1.92%)
GILD   62.90 (-1.63%)
S&P 500   3,283.22 (-1.27%)
DOW   28,855.84 (-1.04%)
QQQ   221.85 (-1.22%)
AAPL   318.58 (-0.20%)
FB   216.42 (-1.52%)
GOOGL   1,465.76 (-1.28%)
AMZN   1,851.75 (-1.74%)
CGC   22.71 (-7.53%)
NVDA   249.33 (-1.40%)
BABA   211.74 (-3.37%)
MU   57.36 (-3.11%)
TSLA   557.57 (-2.56%)
AMD   49.61 (-4.06%)
T   38.25 (-0.98%)
F   8.97 (-1.86%)
NFLX   349.09 (-0.15%)
PRI   122.73 (-2.25%)
BAC   33.36 (-2.23%)
DIS   139.47 (-1.92%)
GILD   62.90 (-1.63%)
S&P 500   3,283.22 (-1.27%)
DOW   28,855.84 (-1.04%)
QQQ   221.85 (-1.22%)
AAPL   318.58 (-0.20%)
FB   216.42 (-1.52%)
GOOGL   1,465.76 (-1.28%)
AMZN   1,851.75 (-1.74%)
CGC   22.71 (-7.53%)
NVDA   249.33 (-1.40%)
BABA   211.74 (-3.37%)
MU   57.36 (-3.11%)
TSLA   557.57 (-2.56%)
AMD   49.61 (-4.06%)
T   38.25 (-0.98%)
F   8.97 (-1.86%)
NFLX   349.09 (-0.15%)
PRI   122.73 (-2.25%)
BAC   33.36 (-2.23%)
DIS   139.47 (-1.92%)
GILD   62.90 (-1.63%)
S&P 500   3,283.22 (-1.27%)
DOW   28,855.84 (-1.04%)
QQQ   221.85 (-1.22%)
AAPL   318.58 (-0.20%)
FB   216.42 (-1.52%)
GOOGL   1,465.76 (-1.28%)
AMZN   1,851.75 (-1.74%)
CGC   22.71 (-7.53%)
NVDA   249.33 (-1.40%)
BABA   211.74 (-3.37%)
MU   57.36 (-3.11%)
TSLA   557.57 (-2.56%)
AMD   49.61 (-4.06%)
T   38.25 (-0.98%)
F   8.97 (-1.86%)
NFLX   349.09 (-0.15%)
PRI   122.73 (-2.25%)
BAC   33.36 (-2.23%)
DIS   139.47 (-1.92%)
GILD   62.90 (-1.63%)
Log in

NASDAQ:BMTI - BioMimetic Therapeutics Stock Price, Forecast & News

Notice: This company has been marked as potentially delisted and may not be actively trading.
Add
Today's Range N/A
50-Day Range N/A
52-Week Range N/A
VolumeN/A
Average VolumeN/A
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
BioMimetic Therapeutics, Inc is a biotechnology company engaged in developing and commercializing products to the healing of musculoskeletal injuries and diseases, including therapies for orthopedic, sports medicine and spine applications. The Company's Augment platform of product and product candidates include an engineered version of recombinant human platelet-derived growth factor BB (rhPDGF-BB), one of the wound healing and tissue repair stimulators in the body. Read More…

Industry, Sector and Symbol

Industry N/A
Sub-IndustryN/A
SectorN/A
Current SymbolNASDAQ:BMTI
CUSIPN/A
Phone+1-615-8441280

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

EmployeesN/A
Next Earnings DateN/A
OptionableNot Optionable

Receive BMTI News and Ratings via Email

Sign-up to receive the latest news and ratings for BMTI and its competitors with MarketBeat's FREE daily newsletter.


BioMimetic Therapeutics (NASDAQ:BMTI) Frequently Asked Questions

What is BioMimetic Therapeutics' stock symbol?

BioMimetic Therapeutics trades on the NASDAQ under the ticker symbol "BMTI."

Has BioMimetic Therapeutics been receiving favorable news coverage?

Media headlines about BMTI stock have trended somewhat negative this week, InfoTrie reports. The research group identifies negative and positive media coverage by reviewing more than six thousand news and blog sources in real-time. The firm ranks coverage of companies on a scale of negative five to positive five, with scores closest to five being the most favorable. BioMimetic Therapeutics earned a news impact score of -1.0 on InfoTrie's scale. They also gave news stories about the biotechnology company a news buzz of 10.0 out of 10, indicating that recent media coverage is extremely likely to have an impact on the stock's share price in the immediate future. View News Stories for BioMimetic Therapeutics.

What is BioMimetic Therapeutics' official website?

The official website for BioMimetic Therapeutics is http://biomimetics.com/.

How can I contact BioMimetic Therapeutics?

BioMimetic Therapeutics' mailing address is 389 Nichol Mill Lane, FRANKLIN, TN 37067, United States. The biotechnology company can be reached via phone at +1-615-8441280.


MarketBeat Community Rating for BioMimetic Therapeutics (NASDAQ BMTI)

Community Ranking:  2.3 out of 5 (star star)
Outperform Votes:  69 (Vote Outperform)
Underperform Votes:  81 (Vote Underperform)
Total Votes:  150
MarketBeat's community ratings are surveys of what our community members think about BioMimetic Therapeutics and other stocks. Vote "Outperform" if you believe BMTI will outperform the S&P 500 over the long term. Vote "Underperform" if you believe BMTI will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 1/24/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel